ISAD has received a message from colleagues of the Netherlands asking for help on phototherapy of AD, a “vanishing” field with the development of systemics, to be covered in Gdansk (session 5: Topical treatment and phototherapy: endangered regimens?).
They would like to invite experts (dermatologists) on phototherapy for AD to participate in an eDelphi consensus study because evidence-based guidelines on when and how to apply this treatment for AD are at best limited. If you are interested in participating, please contact: